Prostate Cancer New

Featured Article

Drugmaker AstraZeneca is moving its experimental prostate cancer treatment into Phase III clinical trials. The medication--called ZD4054--is designed to treat men whose cancer appears to be resistant to hormone therapy. The Phase III trial is expected to begin later this year.

Read more

More information on "Prostate Cancer New"

From Our Experts

See more SharePosts »

From Our Sources

More on Prostate »